- Legend Biotech USA, Inc. (Piscataway, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... with other lab duties. The ideal candidate has experience in immune-oncology and/or CAR natural killer (NK) and/or gamma-delta (gd) T cells and is willing to embrace… more
- CHRISTUS Health (Alamogordo, NM)
- …quality of life? Alamogordo, NM, beckons you with its unique blend of natural beauty, family-friendly atmosphere, and diverse economic opportunities. As a PMHNP, you ... and playing golf in the afternoons, all surrounded by the breathtaking natural beauty of Alamogordo. Family-Friendly Environment: Join a community known for its… more
- Merck & Co. (Rahway, NJ)
- …related topics. A driven, hands-on, and energetic personality, (s)he will be a natural self-starter with a focused approach to problem solving and a willingness to ... roll their sleeves up to achieve their objectives.The role will require regional and international travel up to 40% of the time.Key Capabilities Fosters collaboration - Creates a pervasive attitude within own team/unit that everyone's work is important and… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Eisai, Inc (Nutley, NJ)
- …economic projects including but not limited to: advanced models ( natural history, microsimulation, Markov, compartmental, among others); applied health economic ... models (cost-utility, cost-effectiveness, budget-impact, burden of illness, etc.) as well as the potential for observational health economic studies (prospective or retrospective study of cost and/or outcomes).Conduct systematic literature reviews, comparative… more
- Merck & Co. (Rahway, NJ)
- …and platforms like Robotic Process Automation, Machine Learning, and Natural Language Processing.Familiarity with AI techniques including machine learning ... algorithms, predictive analytics, and deep learning frameworks.Excellent problem-solving skills with the ability to think strategically and analytically.Strong communication and interpersonal skills to collaborate effectively with cross-functional teams and… more
- Daiichi Sankyo, Inc. (Basking Ridge, NJ)
- …and machine learning (ML) techniques. Experience with Gen AI, deep learning, natural language processing (NLP), and predictive modeling is a plus. Travel:Ability to ... travel up to 5% Occasional travel for meetings and seminarsDaiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation,… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Piscataway, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. Legend Biotech entered into a global ... collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel) in 2017. Our strategic partnership is designed to combine the strengths and expertise of… more
Related Job Searches:
Natural Adabas,
Natural Foods,
Natural Gas,
Natural Gas Risk,
Natural Health,
Natural Language,
Natural Products,
Natural Products Industry,
Natural Resources,
Natural Sales